CryoPort (CYRX)
(Delayed Data from NSDQ)
$7.13 USD
+0.15 (2.15%)
Updated Oct 14, 2024 03:59 PM ET
After-Market: $7.12 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Income Statements
Fiscal Year end for CryoPort, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 233 | 237 | 223 | 79 | 34 |
Cost Of Goods | 134 | 133 | 126 | 42 | 17 |
Gross Profit | 99 | 104 | 97 | 36 | 17 |
Selling & Adminstrative & Depr. & Amort Expenses | 214 | 136 | 114 | 66 | 35 |
Income After Depreciation & Amortization | -115 | -32 | -18 | -30 | -18 |
Non-Operating Income | 21 | 3 | -251 | 0 | 1 |
Interest Expense | 6 | 6 | 5 | 3 | 1 |
Pretax Income | -99 | -35 | -274 | -33 | -18 |
Income Taxes | 0 | 2 | 2 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -100 | -37 | -276 | -33 | -18 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -100 | -37 | -276 | -33 | -18 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -36 | -7 | 4 | -20 | -15 |
Depreciation & Amortization (Cash Flow) | 80 | 25 | 21 | 10 | 3 |
Income After Depreciation & Amortization | -115 | -32 | -18 | -30 | -18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.74 | 48.99 | 45.93 | 38.58 | 33.39 |
Diluted EPS Before Non-Recurring Items | -1.41 | -0.87 | -1.85 | -0.84 | -0.55 |
Diluted Net EPS (GAAP) | -2.21 | -0.93 | -6.18 | -1.94 | -0.55 |
Fiscal Year end for CryoPort, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 57.60 | 54.59 | 57.26 | 56.16 |
Cost Of Goods | NA | 32.41 | 32.82 | 34.00 | 31.89 |
Gross Profit | NA | 25.19 | 21.78 | 23.26 | 24.27 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 104.42 | 43.05 | 93.13 | 41.17 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -79.23 | -21.27 | -69.87 | -16.90 |
Non-Operating Income | NA | 2.87 | 3.94 | 7.43 | 5.47 |
Interest Expense | NA | 1.25 | 1.34 | 1.31 | 1.36 |
Pretax Income | NA | -77.61 | -18.68 | -63.75 | -12.80 |
Income Taxes | NA | 0.38 | 0.22 | -1.36 | 0.47 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -77.99 | -18.90 | -62.39 | -13.27 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -77.99 | -18.90 | -62.39 | -13.27 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 49.35 | 49.02 | 48.97 | 48.90 |
Diluted EPS Before Non-Recurring Items | NA | -0.33 | -0.43 | -0.51 | -0.31 |
Diluted Net EPS (GAAP) | NA | -1.62 | -0.43 | -1.32 | -0.31 |